Overview of Dr. James
Dr. Scott James is a hematologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of Washington School of Medicine and has been in practice 6 years. He is one of 63 doctors at Memorial Sloan Kettering Cancer Center who specialize in Hematology. He has more than 10 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017
University of WashingtonResidency, Internal Medicine, 2011 - 2014- University of Washington School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
CA State Medical License 2024 - 2026
NY State Medical License 2014 - 2025
WA State Medical License 2011 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsLeucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.Scott E James, Sophia Chen, Brandon D Ng, Jacob S Fischman, Lorenz Jahn
Nature Biomedical Engineering. 2024-12-01 - 5 citationsIL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model.Brandon D Ng, Adhithi Rajagopalan, Anastasia I Kousa, Jacob S Fischman, Sophia Chen
Blood. 2024-07-11 - 10 citationsA therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cellsJoshua R. Veatch, Naina Singhi, Shivani Srivastava, Julia L. Szeto, Brenda Jesernig
The Journal of Clinical Investigation. 2021-08-16
Press Mentions
Research by City of Hope and Other Scientists May Help Patients Overcome Resistance to Chimeric Antigen Receptor (CAR) T Cell TherapyDecember 23rd, 2024- City of Hope Research Spotlight, September 2024September 23rd, 2024
Grant Support
- Multi-antigen-specific CAR T cells to treat acute myeloid leukemiaBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
